Eli Lilly and Company (LLY) is expected to report earnings on Thursday, October 29, 2026, after the close. Estimated release time 07:05 ET. Consensus EPS estimate is $9.85.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-05 | FY2026 Q2 | $6.40 | $7.95 | +24.2% | $22.97B |
| 2026-04-30 | FY2026 Q1 | $6.97 | $8.27 | +18.7% | $19.80B |
| 2026-02-12 | FY2025 Q4 | $6.91 | $7.41 | +7.2% | $19.29B |
| 2025-10-30 | FY2025 Q3 | $5.69 | $7.02 | +23.4% | $17.60B |
| 2025-08-07 | FY2025 Q2 | $5.60 | $6.30 | +12.5% | $15.56B |
| 2025-05-01 | FY2025 Q1 | $3.26 | $3.34 | +2.5% | $12.73B |
| 2025-02-19 | FY2024 Q4 | $5.03 | $5.32 | +5.8% | $13.53B |
| 2024-10-30 | FY2024 Q3 | $1.47 | $1.18 | -19.7% | $11.44B |
LLY has beaten consensus EPS in 7 of its last 8 reported quarters.
See LLY on the live calendar →